English
Segment disclosures
Company overviewSepterna, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 4 retained observations 2 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
G Protein Coupled Receptor
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=sepn:GProteinCoupledReceptorMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-07-01 – 2026-09-30 | 18881000 | USD | 20261109 | Open filing evidence |
| 2026-01-01 – 2026-09-30 | 72150000 | USD | 20261109 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 21495000 | USD | 20261109 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 21833000 | USD | 20261109 | Open filing evidence |